Sourcing and managing high-cost specialty medications can be complex—especially when healthcare organizations are expected to balance speed, affordability, and consistency across growing patient populations.
At ExhaleRx, we simplify that process.
Our role is to provide reliable access to branded specialty and chronic-care medications, delivered with precision and supported by pricing structures that make long-term programs sustainable 💡
🌍 Built for the Realities of Modern Healthcare
Healthcare today operates across multiple stakeholders, each with distinct operational needs.
ExhaleRx is purpose-built to support:
- PBMs (Pharmacy Benefit Managers) 🧾
- TPAs (Third-Party Administrators) 🤝
- Direct Primary Care (DPC) networks 🏥
- Self-funded employer health plans 👥
- Brokers and benefit consultants 📊
- Specialty and chronic-care clinics
By supporting these groups, we enable medication access at both the individual patient level and the population level—without adding operational friction.
💊 Branded Medications We Support
ExhaleRx specializes exclusively in branded medications, ensuring consistent quality, authenticity, and reliability across all therapies we fulfill.
🟣 Specialty & Biologic Medications
We support a wide range of high-value injectable and oral biologics, including:
- Enbrel (Etanercept) – 50mg SureClick pens & prefilled syringes
- Skyrizi (Risankizumab) – 150mg & 360mg autoinjectors
- Rinvoq (Upadacitinib) – 15mg & 30mg tablets
- Humira (Adalimumab) – 40mg & 80mg pens
- Dupixent (Dupilumab) – 300mg / 2mL prefilled pens
- Stelara
- Taltz
- Cimzia
- Orencia
These therapies support patients managing autoimmune, inflammatory, and chronic conditions—where consistency and predictability are essential
🟢 GLP-1 Therapies
We also support GLP-1 medications used in diabetes management and weight-management programs:
- Mounjaro
- Ozempic
- Wegovy
Our model is designed to support ongoing GLP-1 programs, not one-off fulfillment—helping partners scale confidently 📈
⏱️ How ExhaleRx Delivers
Our fulfillment model is built around efficiency, transparency, and repeatability—so logistics stay in the background while care stays front and center.
🔹 Average Delivery Time: ~36 hours nationwide
🔹 Cold-Chain Packaging: Full temperature control from origin to doorstep ❄️
🔹 End-to-End Coordination: From provider prescription to patient delivery
🔹 Real-Time Tracking: Full visibility for partners and patients 📦
This approach helps protect therapy schedules, reduce operational burden, and improve the overall care experience.
💰 Attractive Pricing That Supports Long-Term Care
Affordability plays a meaningful role in access—but only when it supports continuity, not short-term decisions.
Through operational efficiency and scale, ExhaleRx offers highly competitive pricing across branded specialty and chronic-care medications—often delivering significant savings compared to traditional U.S. wholesale channels.
These pricing structures are designed to:
- Support long-term therapy adherence
- Enable population-level programs
- Reduce financial pressure on benefit models
- Improve sustainability for employers and care organizations
📊 Value, when paired with reliability, becomes a foundation for better care.
🤝 Why Partners Choose ExhaleRx
Organizations work with ExhaleRx because we combine execution discipline with program-level thinking.
Partners benefit from:
- Access to hard-to-source branded specialty medications
- Meaningful cost savings without compromising consistency
- Dedicated account management and concierge-level support
- Transparent communication and shipment visibility
- Infrastructure designed specifically for PBMs, DPCs, TPAs, and self-funded plans
Our goal is not to disrupt care workflows—but to strengthen them.
At ExhaleRx, our mission is simple:
💡 Improve access to branded specialty and chronic-care medications by delivering speed, value, and precision—at scale.
When fulfillment works quietly and reliably, patients stay on therapy, providers stay focused on care, and healthcare organizations gain confidence to grow.
#ExhaleRx #SpecialtyPharmacy #GLP1 #Enbrel #Skyrizi #Rinvoq #Humira #Dupixent #Stelara #Cimzia #Ozempic #Wegovy #Mounjaro
#SelfFundedPlans #PBMs #DPC #ChronicCare #DiabetesManagement #PharmaSavings #ColdChain
#HealthcareInnovation #PharmacyLogistics #BrandedMedications #PatientCare
#HealthcareSavings #BenefitOptimization #EmployeeHealth #AffordableHealthcare #IntegratedCare
